Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alembic Pharmaceuticals Limited ( (IN:APLLTD) ) just unveiled an update.
Alembic Pharmaceuticals Limited announced the successful completion of a United States Food and Drug Administration (USFDA) inspection at its API-III Facility in Karakhadi. The inspection, which took place from March 17 to March 21, 2025, concluded without any Form 483 observations, indicating compliance with Good Manufacturing Practices (GMP). This achievement is likely to bolster the company’s reputation in the pharmaceutical industry, ensuring continued trust from stakeholders and potentially enhancing its market position.
More about Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is a company in the pharmaceutical industry, focusing on the development, manufacture, and marketing of pharmaceutical products. The company primarily deals with active pharmaceutical ingredients (APIs) and formulations, serving both domestic and international markets.
YTD Price Performance: -19.71%
Average Trading Volume: 5,427
Current Market Cap: 164.2B INR
See more insights into APLLTD stock on TipRanks’ Stock Analysis page.